| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| NMA1272 | PBPRA1645 | PBPRA1643 | PBPRA1645 | Conserved hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.530 |
| NMA1272 | VVA1570 | PBPRA1643 | PBPRA1644 | Conserved hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.762 |
| PBPRA1645 | NMA1272 | PBPRA1645 | PBPRA1643 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Conserved hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.530 |
| PBPRA1645 | VVA1570 | PBPRA1645 | PBPRA1644 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.537 |
| PLU1241 | S0421 | PBPRA0836 | PBPRA1016 | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | 0.802 |
| PLU1241 | STM2669 | PBPRA0836 | PBPRA3025 | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | 0.764 |
| PLU1241 | VVA1570 | PBPRA0836 | PBPRA1644 | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.420 |
| PLU1241 | Z4768 | PBPRA0836 | PBPRA0178 | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | Hypothetical ComF-related protein; Predicted by orpheus program; predicted by glimmer program. | 0.754 |
| S0421 | PLU1241 | PBPRA1016 | PBPRA0836 | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | 0.802 |
| S0421 | STM2669 | PBPRA1016 | PBPRA3025 | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | 0.764 |
| S0421 | VVA1570 | PBPRA1016 | PBPRA1644 | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.420 |
| S0421 | Z4768 | PBPRA1016 | PBPRA0178 | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | Hypothetical ComF-related protein; Predicted by orpheus program; predicted by glimmer program. | 0.754 |
| STM2669 | PLU1241 | PBPRA3025 | PBPRA0836 | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | 0.764 |
| STM2669 | S0421 | PBPRA3025 | PBPRA1016 | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | 0.764 |
| STM2669 | VVA1570 | PBPRA3025 | PBPRA1644 | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.463 |
| STM2669 | Z4768 | PBPRA3025 | PBPRA0178 | Putative chorismate mutase/prephenate dehydrogenase; Predicted by orpheus program; predicted by glimmer program. | Hypothetical ComF-related protein; Predicted by orpheus program; predicted by glimmer program. | 0.824 |
| VVA1570 | NMA1272 | PBPRA1644 | PBPRA1643 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Conserved hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.762 |
| VVA1570 | PBPRA1645 | PBPRA1644 | PBPRA1645 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | 0.537 |
| VVA1570 | PLU1241 | PBPRA1644 | PBPRA0836 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Putative xanthine-guanine phosphoribosyltransferase; Acts on guanine, xanthine and to a lesser extent hypoxanthine; Belongs to the purine/pyrimidine phosphoribosyltransferase family. XGPT subfamily. | 0.420 |
| VVA1570 | S0421 | PBPRA1644 | PBPRA1016 | Hypothetical protein; Predicted by orpheus program; predicted by glimmer program. | Putative adenine phosphoribosyltransferase; Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. | 0.420 |